Effects of three‐month streptozotocin‐induced diabetes in mice on blood platelet reactivity, COX‐1 expression and adhesion potential
Open Access
- 27 February 2019
- journal article
- research article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 100 (1) , 41-48
Abstract
Summary: Diabetes is associated with an increased risk of cardiovascular disease. This is partially attributed to an altered activation status of blood platelets in this disease. Previously, alterations have been shown in COX‐1 and protease activated receptor (PAR)‐3 receptor expression in platelets in two animal models of diabetes, there have not been studies which address expression of these proteins in mice with long‐term streptozotocin (STZ)‐induced diabetes. We have also addressed the effect of diabetes on platelet adhesion under flow conditions. With the use of flow cytometry, we have shown that certain markers of platelet basal activation, such as active form of αIIbβ3 and of CD40L were increased in STZ‐induced diabetic mice. Platelets from STZ‐induced diabetic mice were also more reactive when stimulated with PAR‐4 activating peptide as revealed by higher expression of active form of αIIbβ3, membrane‐bound on vWillebrand Factor and binding of exogenous fluorescein isothyanate‐labelled fibrinogen. Expression of COX‐1 and production of thromboxane A2 in platelets of STZ‐induced diabetic mice were higher than in control animals. We observed no effect of diabetes on ability of platelets to form stable adhesions with fibrinogen in flow conditions. We conclude that although certain similarities exist between patterns of activation of platelets in animal models of diabetes, the differences should also be taken into account.Keywords
Funding Information
- Narodowe Centrum Nauki (MAESTRO UMO‐2012/06/A/N25/00069, 2016/20/T/NZ3/00508, 2016/20/T/NZ3/00505)
This publication has 28 references indexed in Scilit:
- Impact of Diabetes on Cardiovascular Disease: An UpdateInternational Journal of Hypertension, 2013
- Diabetes Alters Intracellular Calcium Transients in Cardiac Endothelial CellsPLOS ONE, 2012
- Anti‐platelet therapy: cyclo‐oxygenase inhibition and the use of aspirin with particular regard to dual anti‐platelet therapyBritish Journal of Clinical Pharmacology, 2011
- Review article: Platelet abnormalities in diabetes mellitusDiabetes & Vascular Disease Research, 2010
- Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic ratBritish Journal of Pharmacology, 2007
- Long‐term streptozotocin‐induced diabetes alters prostanoid production in rat aorta and mesenteric bedAutonomic & Autacoid Pharmacology, 2006
- Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of β1 and β2 integrinsJournal of Leukocyte Biology, 2006
- A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion FormationJournal of Experimental Medicine, 2002
- Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbαJournal of Experimental Medicine, 1998
- Thromboxane Biosynthesis and Platelet Function in Type II Diabetes MellitusNew England Journal of Medicine, 1990